SCHEMBL29360430

SCHEMBL29360430

CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N\OC(c5ccccc5)c5ccccc5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCB11 O95342 5/20 0.76
▸ MAPT P10636 4/20 0.76
▸ ABCC4 O15439 4/20 0.76
▸ ABCC2 Q92887 4/20 0.76
▸ GAA P10253 3/20 0.76
▸ MAPK1 P28482 3/20 0.76
▸ ABCC3 O15438 3/20 0.76
▸ TBXA2R P21731 3/20 0.76
▸ NR1I2 O75469 3/20 0.76
▸ CHRM1 P11229 3/20 0.76
▸ ALDH1A1 P00352 2/20 0.76
▸ KDM4E B2RXH2 2/20 0.76
▸ MEN1 O00255 2/20 0.76
▸ KMT2A Q03164 2/20 0.76
▸ TDP1 Q9NUW8 2/20 0.76
▸ SLCO2B1 O94956 2/20 0.76
▸ ADRA1A P35348 2/20 0.76
▸ SLCO1A2 P46721 2/20 0.76
▸ SLCO1B3 Q9NPD5 2/20 0.76
▸ SLCO1B1 Q9Y6L6 2/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29625754 1.00 ABCB11 (0.76) ABCB11MAPTABCC4ABCC2GAA
SCHEMBL29625771 0.93 ABCB11 (0.80) ABCB11MAPTABCC4ABCC2GAA
SCHEMBL23510705 0.92 MAPT (0.83) ABCB11MAPTABCC4ABCC2GAA
SCHEMBL23541652 0.92 MAPT (0.83) ABCB11MAPTABCC4ABCC2GAA
SCHEMBL29625743 0.91 ABCB11 (0.76) ABCB11MAPTABCC4ABCC2GAA
SCHEMBL30248391 0.91 ABCB11 (0.74) ABCB11MAPTABCC4ABCC2GAA
SCHEMBL23541658 0.90 ABCB11 (0.83) ABCB11MAPTABCC4ABCC2GAA
SCHEMBL23594215 0.90 ABCB11 (0.83) ABCB11MAPTABCC4ABCC2GAA
SCHEMBL29559659 0.90 ABCB11 (0.83) ABCB11MAPTABCC4ABCC2GAA
SCHEMBL30073972 0.90 MAPT (0.76) ABCB11MAPTABCC4ABCC2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 149 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-221676066-U Slag steel cutting safety system 氢环环保科技(上海)有限公司 2024-09-10 — — CN claimed
CN-117564403-A Slag steel cutting safety system 氢环环保科技(上海)有限公司 2024-02-20 — — CN claimed
CN-117245170-A Slag steel cutting safety system 氢环环保科技(上海)有限公司 2023-12-19 — — CN claimed
US-20230286844-A1 METHOD FOR DECONTAMINATING ENVIRONMENT POLLUTED WITH PETROLEUM-RELATED MATERIAL, AND MATERIAL USED IGA BIO RESEARCH CO., LTD. (JP) 2023-09-14 — — US claimed
CN-112980912-B Method for increasing yield of perylenequinone secondary metabolites produced by bamboo yellow fermentation 华南理工大学 2023-03-28 — — CN claimed
US-12635706-B2 Process to prepare a liquid coffee concentrate with reduced acrylamide content by resin treatment KONINKLIJKE DOUWE EGBERTS B.V. (NL) 2026-05-26 — — US disclosed
CN-117221439-B Method, electronic device, and computer-readable storage medium for capturing and recording media in multiple modes 苹果公司 2026-05-22 — — CN disclosed
EP-4724418-A1 TRICINE AND CITRIC ACID-BASED CATIONIC LIPIDS Sanofi (FR) 2026-04-15 — — EP disclosed
EP-3873996-B1 LABELS HEWLETT PACKARD DEVELOPMENT CO (US) 2026-03-11 — — EP disclosed
US-12552787-B2 Quinazoline compound MEDSHINE DISCOVERY INC. (CN) 2026-02-17 — — US disclosed
US-20250314985-A1 ELECTROPHOTOGRAPHIC INK COMPOSITIONS HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2025-10-09 — — US disclosed
EP-3700747-B1 FLEXIBLE PACKAGING MATERIAL HEWLETT PACKARD DEVELOPMENT CO (US) 2025-05-21 — — EP disclosed
US-20220056289-A1 ELECTROPHOTOGRAPHIC INK COMPOSITIONS HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2022-02-24 — — US disclosed
CN-108369391-B Priming a print substrate 惠普印迪戈股份公司 2022-02-22 — — CN disclosed
CN-109071978-B Liquid electrophotographic ink composition 惠普印迪戈股份公司 2022-02-11 — — CN disclosed
US-20220030852-A1 AGROCHEMICAL OIL DISPERSION FORMULATION BASF SE (DE) 2022-02-03 — — US disclosed
US-11236248-B2 Metallic pigment particles HP INDIGO B.V. (NL) 2022-02-01 — — US disclosed
US-11235230-B2 Scratch-off structures HP INDIGO B.V. (NL) 2022-02-01 — — US disclosed
WO-2022019319-A1 ANTIMICROBIAL AGENT AND METHOD FOR MANUFACTURING SAME 株式会社トレスバイオ研究所 2022-01-27 — — WO disclosed
WO-2022017519-A1 QUINAZOLINE COMPOUND 南京明德新药研发有限公司 2022-01-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12635706-B2 Process to prepare a liquid coffee concentrate with reduced acrylamide content by resin treatment SAAL1, HAAO, HACL2 ABCB11 2745/4885MAPT 2164/4885ABCC4 959/4885
US-12552787-B2 Quinazoline compound SLC9A3, CLIC1, NHERF1 ABCB11 4/4885MAPT 4473/4885ABCC4 52/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback